Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Serous Adenocarcinoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Glandular Cell Neoplasm
Serous Neoplasm
Serous Adenocarcinoma

Histology

Serous Adenocarcinoma

CI-CAN-00003907Explore in graph →

85 active trials9 evidence items

NCIt: C40101

Overview
Statistics
Survival
Genomics8
Variants & evidence9
Drugs8
Trials210
Research
Rankings
Sources & provenance

Data completeness4 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (no data yet)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

An adenocarcinoma that is characterized by the presence of papillary patterns and cellular budding. Psammoma bodies may be present. Representative examples include cervical serous adenocarcinoma, endometrial serous adenocarcinoma, ovarian serous adenocarcinoma, and primary peritoneal serous adenocarcinoma.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

AdenocarcinomaHistology
Serous NeoplasmHistology

Children (12)

ncit

Broad Ligament Serous Adenocarcinoma
Cervical Serous Adenocarcinoma
Endometrial Serous Adenocarcinoma1 sub
Fallopian Tube Serous Adenocarcinoma2 sub
High Grade Serous Adenocarcinoma3 sub
Low Grade Serous Adenocarcinoma2 sub
Micropapillary Serous Carcinoma
Ovarian Serous Adenocarcinoma6 sub

Anatomy

Anatomical sites

Data not yet available

No anatomical site linked yet.

Record

Identity

CancerIndex ID: CI-CAN-00003907
Entity type: Histology
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 5
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

Primary Peritoneal Serous Adenocarcinoma3 sub

Serous Cystadenocarcinoma4 sub

Serous Endometrial Intraepithelial Carcinoma

Serous Surface Papillary Carcinoma2 sub

33 descendants in total; counters on this page aggregate over all of them.

210 / 85

Publications (all / 5y)

748 / 102

Evidence items

9

Genes / variants

119 / 8

Drugs (any / approved)

8 / 0

Genomic cohorts

8

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (0)

Only the preferred name is recorded so far.

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials85countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #210 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials35countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #241 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items9countaccepted CIViC items · entity + descendantscivicComputedrank #202 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months13countPubMed records · stored query · 12-month windowpubmedComputedrank #881 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts8countopen GDC projects · entity + descendantsgdcComputedrank #119 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 18 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants